Deal date
KANDO id: 729796
Financial Transaction:
Acquisition
Stemcentrx Inc
Currency
United States Dollar
Value in original currency
10,200,000,000
Company valuation (pre money)
10,200,000,000
Value in USD
10,200,000,000
Company valuation in USD (pre money)
10,200,000,000
Note
The deal includes USD5.8 billion in upfront payments, includingUSD2 billion in stock, as well as USD4 billion in cash-based earnouts, plus a return to shareholders of Stemcentrx of cash on hand.
Round participants
| Investor | Country | Notes | |
|---|---|---|---|
|
Abbvie Inc |
United States | 10,200,000,000 (USD 10,200,000,000) Initial investment. |